Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
Health Services Research|June 4, 2025
Completeness and Quality of Data for Children in Medicaid Comprehensive Managed Care Compared to Fee-for-Service, 2001-2019Kristen Lloyd, Sanika Rege, Stephen Crystal, et al.
JAMA Neurology|July 10, 2023
Initiation Patterns of Disease-Modifying Therapies for Multiple Sclerosis Among US Adults and Children, 2001 Through 2020Mackenzie Henderson, Daniel B Horton, Vikram Bhise, et al.
Plos One|December 10, 2020
Heatwaves, medications, and heat-related hospitalization in older Medicare beneficiaries with chronic conditionsJ Bradley Layton, Wenhong Li, Jiacan Yuan, et al.
Neurology|June 11, 2025
Risk of Ventricular Arrhythmia and Sudden Cardiac Arrest Among Older Patients Using Lamotrigine for EpilepsyGloria Y F Ho, Daniel B Horton, Parin J Patel, et al.
Pediatrics|September 19, 2019
Trends in Off-Label Drug Use in Ambulatory Settings: 2006-2015Divya Hoon, Matthew T Taylor, Pooja Kapadia, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|November 27, 2023
Acid-suppressive medication and incidence of chronic childhood immune-mediated diseases: A scoping reviewJoanna Madej, Tania Atanassova, Sarah McGuire, et al.
Parkinsonism & Related Disorders|August 4, 2024
Effects of antimicrobial exposure on the risk of Parkinson's diseaseGian Pal, Laura Bennett, Jason Roy, et al.
Journal of Child and Adolescent Psychopharmacology|December 20, 2024
Current Utilization of Bupropion Treatment in Children, Young Adults, and Adults in the United StatesGreta A Bushnell, Daniel B Horton, Mark Olfson, et al.
Arthritis Care & Research|April 3, 2026
Cumulative Social Disadvantage and Disease Activity in Juvenile Idiopathic Arthritis: A Childhood Arthritis and Rheumatology Research Alliance Registry StudyWilliam Daniel Soulsby, John Boscardin, Andrea Knight, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 22, 2024
Trends in New Use of Disease-Modifying Antirheumatic Drugs for Juvenile Idiopathic Arthritis Among Commercially Insured Children in the United States from 2001 to 2022Priyanka Yalamanchili, Lydia Y Lee, Greta Bushnell, et al.
Pageof 10